Вход на сайт
Просмотр новости

Найдите то, что Вас интересует

No improvement in OS, but more grade 3 or higher AEs with atezolizumab plus SBRT among patients with inoperable early-stage NSCLC
Дата публикации: 24-09-2026 07:00:00

Findings from the SWOG/NRG S1914 study

Основное содержимое страницы с новостью.

Subscribe to ESMO newsletter

Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.

ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH

© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Adjuvant fractionated radiotherapy significantly improves DFS in patients with atypical meningioma who have undergone complete surgical resection01008-10-2026
2Tambotatug pelitecan leads to better clinical outcomes than topotecan among patients with relapsed SCLC after platinum-based therapy014.5528-09-2026
3FDA grants accelerated approval to vusolimogene oderparepvec-wtpg in combination with nivolumab for melanoma012.1430-09-2026
4EMA Recommends Granting a Marketing Authorisation for Ensartinib013.6109-10-2026
5В Орловском онкодиспансере внедряют ускоренный курс лечения рака легких01030-09-2026
6Annual multicancer early detection test not associated with a lower incidence rate of stage III or IV cancer after three screening rounds and 12 months of follow-up017.3601-10-2026
7Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer07.4823-09-2026
8GSK’s B7-H3-targeted antibody-drug conjugate, risvutatug rezetecan, granted Orphan Drug Designation for small-cell lung cancer in Japan014.9123-03-2026
9ASTRO: Fractionated Radiosurgery Boosts Survival With Brain Metastases013.606-10-2026

Классификация: . Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 16.41. Источник: www.esmo.org.